Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson's Disease, LMX.5 Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson's Disease, LMX.5 New York, 02/04/2025 / 09:01, EST/EDT - EQS Newswire - Laxxon Medical Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery systems, today announced the positive results from the...